The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Omega awaits approval of Visitect under new UK regulations

Thu, 04th Nov 2021 06:55

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics company - Notes the UK Health Security Agency's medical devices regulations, which were implemented on Monday. The new regulations require all suppliers of Covid-19 tests to submit information for desktop review prior to the end of October if they want their products to remain on sale in the UK after this date. Omega says it has submitted all documentation ahead of the deadlines and paid the necessary fee, but its Visitect professional-use Covid-19 antigen test has yet to be approved.

Current stock price: 46.50 pence

Year-to-date change: down 28%

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
6 Sep 2023 16:40

TRADING UPDATES: Solid State sees strong orders in security & defence

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

30 Aug 2023 15:44

UK shareholder meetings calendar - next 7 days

22 Aug 2023 10:41

Omega Diagnostics finance director steps down with immediate effect

(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...

3 Aug 2023 14:08

Omega Diagnostics says revenue and loss hurt by operational issues

(Alliance News) - Omega Diagnostics Group PLC on Thursday said its annual loss widened as operational difficulties caused its revenue to plunge.

27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.